Lester is an independent researcher and entrepreneur residing in Maine, United States whose current studies are focused on underrepresented pathogens and historical approaches to combating their resulting diseases. His work centers on targeting immunodeficiencies to prevent future large-scale infections in vulnerable populations, and in leveraging shared knowledge of botanical and organic compounds toward achieving this goal. He believes that approaching future medical treatments by first acknowledging trends in the archaeological record is necessary for true progress.
Through his tenure in medical informatics as a patient-to-provider liaison, Lester came to understand that non-standard approaches should be considered alongside current standards of care. This led to his establishment of a harm-reduction corporation that focused on reducing smoking-related illness and death by application of novel technologies. Improving the health of others by better understanding the commonalities of human biology should be a primary objective of modern medicine.